Radiation Retinopathy Is Treatable With Anti-Vascular Endothelial Growth Factor Bevacizumab (Avastin)

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 4, 2008, Pages 974-977

  Finger, Paul T ^a  

^a NEW YORK EYE CANCER CENTER   (United States)

Author keywords

Avastin; Bevacizumab; Intravitreal; Radiation; Retinopathy

Indexed keywords

PROTEINS; STABILIZATION; TISSUE; VISION;

AVASTIN; BEVACIZUMAB; RETINOPATHY;

RADIOTHERAPY;

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; EYE DISEASE; EYE EXAMINATION; FEMALE; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOSCOPE; PRIORITY JOURNAL; RADIATION SICKNESS; RETINA ANGIOGRAPHY; RETINA MACULA LUTEA; RETINOPATHY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROID NEOPLASMS; HUMANS; INJECTIONS; MELANOMA; MIDDLE AGED; PALLADIUM; RADIATION INJURIES; RADIOISOTOPES; RETINA;

EID: 39749146643     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.045     Document Type: Article

References (15)

1. Finger P.T. Radiation therapy for choroidal melanoma. Surv Ophthalmol 42 (1997) 215-232
2. Parsons J.T., Bova F.J., Fitzgerald C.R., et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30 (1994) 765-773
3. Gardiner T.A., Amoaku W.M., and Archer D.B. The combined effect of diabetes and ionising radiation on the retinal vasculature of the rat. Curr Eye Res 12 (1993) 1009-1014
4. Finger P.T., and Murphree A.L. Ophthalmic brachytherapy: Treatment of choroidal melanoma and retinoblastoma. In: Peyman G.A., Meffert S., Conway M.D., et al. (Eds). Vitreoretinal surgical techniques (2001), Martin Dunitz, London 403-418
5. Archer D.B., Amoaku W.M., and Gardiner T.A. Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations. Eye 5 Pt 2 (1991) 239-251
6. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25 (2004) 581-611
7. Finger P.T. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol 143 (2007) 335-338
8. Finger P.T., and Chin K. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 125 (2007) 751-756
9. Rickham P.P. Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br Med J 2 (1964) 177
10. Conn J. HIPPA, 10 years after. Modern Healthcare 36 (2006) 26-28
11. Haik B., Ainbinder D.J., Finger P.T., et al. Part X: Ophthalmic sites [carcinoma of the eyelid, carcinoma of the conjunctiva, malignant melanoma of the conjunctiva, malignant melanoma of the uvea, retinoblastoma, carcinoma of the lacrimal gland, sarcoma of the orbit]. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York 347-384
12. Finger P.T., Berson A., Ng T., et al. Palladium-103 plaque radiotherapy for choroidal melanoma: An 11-year study. Int J Radiat Oncol Biol Phys 54 (2002) 1438-1445
13. Finger P.T., and Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 89 (2005) 730-738
14. Levy R.L., and Miller N.R. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore 35 (2006) 151-157
15. Rosenfeld P.J., Schwartz S.D., Blumenkranz M.S., et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 112 (2005) 1048-1053